BIOMEnd from NutraShure to be included in two supplements targeting gut health

Image | adobe.stock/Donson/peopleimages.com

Distributor and ingredient supplier, NutraShure Distribution, LLC. (NutraShure) revealed in a press release that their ingredient, BIOMEnd, is going to be included in two dietary supplements called Siver Fern’s Postbiotic+ and Beneves’ Xcelerate G3. Launched in May, “BIOMEnd is a patent-pending superior form of butyrate, a four-carbon short-chain fatty acid, that naturally occurs in certain foods and is produced by gut bacteria during the fermentation of dietary fiber.” It is highly soluble, tasteless, and was designed as L-lysine butyrate. Due to its high solubility, the ingredient is able to be formulated into gummies, powders, capsules, and other consumption varieties.

Siver Fern’s Postbiotic+ is fueled by BIOMEnd. As mentioned in the press release, Siver Fern’s Postbiotic+ is designed to support health throughout the body. NutraShure mentioned that the supplement addresses both structural and immune health aspects of gastrointestinal health. The press release also dived into the supplement, Beneves’ Xcelerate G3, in which BIOMEnd is also the hero ingredient. Beneves’ Xcelerate G3 is designed to target weight management and gut health.

Brandon Sojka, CEO and founder at NutraShure, mentioned in the press release how, “BIOMEnd is reshaping the landscape of how we use butyrate in the market by opening the door to so many new potential innovative delivery forms that could not be done before.”

Sojka added, “Postbiotic+ and Xcelerate G3 are two examples of how brands are leveraging BIOMEnd to create innovative formulations. This is just the beginning, and we look forward to collaborating with our partners to explore new applications and delivery forms in 2025 that redefine what is possible with butyrate.”